Committed to horses, powered by science

Equine Vaccines & Innovative Healthcare for Horses

treating chronic diseases such as allergies and respiratory diseases.

We work together with

Evax develops new equine vaccines for the treatment of chronic deseases, allergies and respiratory deseases.

Für viele Pferdekrankheiten gibt es nur sehr limitierte Behandlungsmöglichkeiten, die manchmal leider auch schlechte Wirksamkeit haben. Daher ist es uns ein wichtiges Anliegen, neue, innovative, spezifische und effiziente Pferde Therapeutika zu entwickeln.

Our first therapy candidate is a vaccine for summer eczema.

Summer eczema, also called sweet itch or insect bite hypersensitivity (IBH) is the most prevalent allergic skin disease in horses. It manifests as chronic relapsing seasonal allergic dermatitis (inflammatory reaction of the skin).

Although IBH is the best studied and characterized allergic disease of horses, treatment options are still poor and not even close to satisfactory. Our vision is to end this suffering, developing a vaccine that therapeutically treats and prophylactically prevents summer eczema.

Care for research

With every purchase of our care products for horses you support the further development of effective therapies for chronic diseases, allergies and respiratory diseases in horses.

The founders of EVAX


Dr. Antonia Gabriel (Fettelschoss) ​


Prof. Martin Bachmann​

Do you have a question?